Only Drug to Prevent Premature Births Will Be Pulled from U.S. Market
The maker of the only drug approved to reduce the risk of premature labor in the U.S. wants to pull it off the market—gradually—years after research raised questions about how well it works. Apollo Global Management’s Covis Pharma Group said it is trying to withdraw Makena in an orderly fashion after a U.S. Food and … Read more